Commission Implementing Decision (EU) 2025/459 of 10 March 2025 repealing Implementing Decision (EU) 2024/2410 postponing the expiry date of the approval of dinotefuran for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/decision/2025/459@2025-03-10/en
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products, and in particular Article 14(5) thereof,
After consulting the Standing Committee on Biocidal Products,
Whereas:
(1) Dinotefuran was approved until 31 May 2022 as an active substance for use in biocidal products of product-type 18 by Commission Implementing Regulation (EU) 2015/416, subject to the conditions set out in the Annex to that Regulation (the approval).
(2) On 11 November 2020, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval of dinotefuran for use in biocidal products of product-type 18 (the application). The application was evaluated by the competent authority of Belgium.
(3) Pursuant to Commission Implementing Decision (EU) 2021/1286, the expiry date of approval of dinotefuran for use in biocidal products of product-type 18 was postponed to 30 November 2024, in order to allow sufficient time for the examination of the application. That expiry date was further postponed to 30 November 2025 by Commission Implementing Decision (EU) 2024/2410.
(4) Commission Implementing Regulation (EU) 2025/457 renewed the approval of dinotefuran for use in biocidal products of product-type 18, subject to the conditions in the Annex to that Regulation, including the expiry date of approval. Therefore, it is appropriate to repeal Implementing Decision (EU) 2024/2410 postponing the initial expiry date of the approval of dinotefuran,
HAS ADOPTED THIS DECISION:
Article 1
Implementing Decision (EU) 2024/2410 is repealed.
Article 2
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Done at Brussels, 10 March 2025. For the Commission The President Ursula von der Leyen